|
1
|
Duan G and Walther D: The roles of
post-translational modifications in the context of protein
interaction networks. PLoS Comput Biol. 11:e10040492015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fleuren EDG, Zhang L, Wu J and Daly RJ:
The kinome 'at large' in cancer. Nat Rev Cancer. 16:83–98. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li X, Wilmanns M, Thornton J and Köhn M:
Elucidating human phosphatase-substrate networks. Sci Signal.
6:rs10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nikolaienko RM, Agyekum B and Bouyain S:
Receptor protein tyrosine phosphatases and cancer: New insights
from structural biology. Cell Adhes Migr. 6:356–364. 2012.
View Article : Google Scholar
|
|
5
|
Hardy S, Julien SG and Tremblay ML: Impact
of oncogenic protein tyrosine phosphatases in cancer. Anticancer
Agents Med Chem. 12:4–18. 2012. View Article : Google Scholar
|
|
6
|
Omerovic J, Clague MJ and Prior IA:
Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent
negative regulators of PKB/Akt activation in Ras-mutated cancer
cells. Biochem J. 426:65–72. 2010. View Article : Google Scholar
|
|
7
|
Zhao Y, Scott A, Zhang P, Hao Y, Feng X,
Somasundaram S, Khalil AM, Willis J and Wang Z: Regulation of
paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts
colon tumorigenesis. Oncotarget. Jul 18–2016.Epub ahead of
print.
|
|
8
|
Tarcic G, Boguslavsky SK, Wakim J, Kiuchi
T, Liu A, Reinitz F, Nathanson D, Takahashi T, Mischel PS, Ng T, et
al: An unbiased screen identifies DEP-1 tumor suppressor as a
phosphatase controlling EGFR endocytosis. Curr Biol. 19:1788–1798.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bardelli A, Parsons DW, Silliman N, Ptak
J, Szabo S, Saha S, Markowitz S, Willson JK, Parmigiani G, Kinzler
KW, et al: Mutational analysis of the tyrosine kinome in colorectal
cancers. Science. 300:9492003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Korff S, Woerner SM, Yuan YP, Bork P, von
Knebel Doeberitz M and Gebert J: Frameshift mutations in coding
repeats of protein tyrosine phosphatase genes in colorectal tumors
with micro-satellite instability. BMC Cancer. 8:3292008. View Article : Google Scholar
|
|
11
|
Laczmanska I, Skiba P, Karpinski P,
Bebenek M and Sasiadek MM: Customized array comparative genomic
hybridization analysis of 25 phosphatase-encoding genes in
colorectal cancer tissues. Cancer Genomics Proteomics. 14:69–74.
2017. View Article : Google Scholar :
|
|
12
|
van Roon EHJ, de Miranda NFCC, van
Nieuwenhuizen MP, de Meijer EJ, van Puijenbroek M, Yan PS, Huang
TH, van Wezel T, Morreau H and Boer JM: Tumour-specific methylation
of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal
cancer. Eur J Hum Genet. 19:307–312. 2011. View Article : Google Scholar :
|
|
13
|
Ashktorab H, Rahi H, Wansley D, Varma S,
Shokrani B, Lee E, Daremipouran M, Laiyemo A, Goel A, Carethers JM,
et al: Toward a comprehensive and systematic methylome signature in
colorectal cancers. Epigenetics. 8:807–815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laczmanska I, Karpinski P, Bebenek M,
Sedziak T, Ramsey D, Szmida E and Sasiadek MM: Protein tyrosine
phosphatase receptor-like genes are frequently hypermethylated in
sporadic colorectal cancer. J Hum Genet. 58:11–15. 2013. View Article : Google Scholar
|
|
15
|
Seo Y, Matozaki T, Tsuda M, Hayashi Y,
Itoh H and Kasuga M: Overexpression of SAP-1, a transmembrane-type
protein tyrosine phosphatase, in human colorectal cancers. Biochem
Biophys Res Commun. 231:705–711. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yao Z, Darowski K, St-Denis N, Wong V,
Offensperger F, Villedieu A, Amin S, Malty R, Aoki H, Guo H, et al:
A global analysis of the receptor tyrosine kinase-protein
phosphatase interactome. Mol Cell. 65:347–360. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Noguchi T, Tsuda M, Takeda H, Takada T,
Inagaki K, Yamao T, Fukunaga K, Matozaki T and Kasuga M: Inhibition
of cell growth and spreading by stomach cancer-associated
protein-tyrosine phosphatase-1 (SAP-1) through dephosphorylation of
p130cas. J Biol Chem. 276:15216–15224. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Skrzypczak M, Goryca K, Rubel T, Paziewska
A, Mikula M, Jarosz D, Pachlewski J, Oledzki J and Ostrowski J:
Modeling oncogenic signaling in colon tumors by multidirectional
analyses of microarray data directed for maximization of analytical
reliability. PLoS One. 5:pii: e13091. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Van de Sompele J, De Preter K, Pattyn F,
Poppe B, Van Roy N, De Paepe A and Speleman F: Accurate
normalization of real-time quantitative RT-PCR data by geometric
averaging of multiple internal control genes. Genome Biol.
3:Research0034. 2002.
|
|
21
|
Muller PY, Janovjak H, Miserez AR and
Dobbie Z: Processing of gene expression data generated by
quantitative real-time RT-PCR. Biotechnique. 32:1372–1374.
13761378–1379. 2002.
|
|
22
|
Tost J and Gut IG: DNA methylation
analysis by pyrosequencing. Nat Protoc. 2:2265–2275. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mikula M, Rubel T, Karczmarski J,
Statkiewicz M, Bomsztyk K and Ostrowski J: Beads-free protein
immunoprecipitation for a mass spectrometry-based interactome and
posttranslational modifications analysis. Proteome Sci. 13:232015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Flanagin S, Nelson JD, Castner DG,
Denisenko O and Bomsztyk K: Microplate-based chromatin
immunoprecipitation method, Matrix ChIP: A platform to study
signaling of complex genomic events. Nucleic Acids Res. 36:e172008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets - update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar
|
|
26
|
Sanz-Pamplona R, Berenguer A, Cordero D,
Molleví DG, Crous-Bou M, Sole X, Paré-Brunet L, Guino E, Salazar R,
Santos C, et al: Aberrant gene expression in mucosa adjacent to
tumor reveals a molecular crosstalk in colon cancer. Mol Cancer.
13:462014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Marisa L, de Reyniès A, Duval A, Selves J,
Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D,
Ayadi M, et al: Gene expression classification of colon cancer into
molecular subtypes: Characterization, validation, and prognostic
value. PLoS Med. 10:e10014532013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hinoue T, Weisenberger DJ, Lange CPE,
Noushmehr H, Byun H-M, van Dijk CM, Pan F, Malik S, Van Den Berg
DJ, Shen H, et al: Abstract LB-173: Genome-scale analysis of
aberrant DNA methylation in colorectal cancer. Cancer Res. 71(Suppl
8): LB-1732011. View Article : Google Scholar
|
|
29
|
Tsukamoto S, Ishikawa T, Iida S, Ishiguro
M, Mogushi K, Mizushima H, Uetake H, Tanaka H and Sugihara K:
Clinical significance of osteoprotegerin expression in human
colorectal cancer. Clin Cancer Res. 17:2444–2450. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Shen D, Parsons DW, Bardelli A,
Sager J, Szabo S, Ptak J, Silliman N, Peters BA, van der Heijden
MS, et al: Mutational analysis of the tyrosine phosphatome in
colorectal cancers. Science. 304:1164–1166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sadakata H, Okazawa H, Sato T, Supriatna
Y, Ohnishi H, Kusakari S, Murata Y, Ito T, Nishiyama U, Minegishi
T, et al: SAP-1 is a microvillus-specific protein tyrosine
phosphatase that modulates intestinal tumorigenesis. Genes Cells.
14:295–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Laczmanska I and Sasiadek MM: Tyrosine
phosphatases as a superfamily of tumor suppressors in colorectal
cancer. Acta Biochim Pol. 58:467–470. 2011.PubMed/NCBI
|
|
33
|
Paduano F, Dattilo V, Narciso D, Bilotta
A, Gaudio E, Menniti M, Agosti V, Palmieri C, Perrotti N, Fusco A,
et al: Protein tyrosine phosphatase PTPRJ is negatively regulated
by microRNA-328. FEBS J. 280:401–412. 2013. View Article : Google Scholar
|
|
34
|
Nagano H, Noguchi T, Inagaki K, Yoon S,
Matozaki T, Itoh H, Kasuga M and Hayashi Y: Downregulation of
stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in
advanced human hepatocellular carcinoma. Oncogene. 22:4656–4663.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hoekstra E, Peppelenbosch MP and Fuhler
GM: The role of protein tyrosine phosphatases in colorectal cancer.
Biochim Biophys Acta. 1826:179–188. 2012.PubMed/NCBI
|
|
36
|
Zhao J and Guan J-L: Signal transduction
by focal adhesion kinase in cancer. Cancer Metastasis Rev.
28:35–49. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Van Slambrouck S, Grijelmo C, De Wever O,
Bruyneel E, Emami S, Gespach C and Steelant WF: Activation of the
FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by
alpha1-integrins during colon cancer cell invasion. Int J Oncol.
31:1501–1508. 2007.PubMed/NCBI
|
|
38
|
Takada T, Noguchi T, Inagaki K, Hosooka T,
Fukunaga K, Yamao T, Ogawa W, Matozaki T and Kasuga M: Induction of
apoptosis by stomach cancer-associated protein-tyrosine
phosphatase-1. J Biol Chem. 277:34359–34366. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ito T, Okazawa H, Maruyama K, Tomizawa K,
Motegi S, Ohnishi H, Kuwano H, Kosugi A and Matozaki T: Interaction
of SAP-1, a transmembrane-type protein-tyrosine phosphatase, with
the tyrosine kinase Lck. Roles in regulation of T cell function. J
Biol Chem. 278:34854–34863. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lonsdale J, Thomas J, Salvatore M,
Phillips R, Lo E, Shad S, Hasz R, Walters G, Garcia F, Young N, et
al GTEx Consortium: The Genotype-Tissue Expression (GTEx) project.
Nat Genet. 45:580–585. 2013. View Article : Google Scholar
|
|
41
|
Wang ZH, Gao QY and Fang JY: Loss of PTEN
expression as a predictor of resistance to anti-EGFR monoclonal
therapy in metastatic colorectal cancer: Evidence from
retrospective studies. Cancer Chemother Pharmacol. 69:1647–1655.
2012. View Article : Google Scholar : PubMed/NCBI
|
